1. IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy
- Author
-
Hidekazu Nakanishi, Yasumasa Monobe, Yoshiyuki Oshiro, Nagio Takigawa, Masataka Taoka, Nobuaki Ochi, Nozomu Nakagawa, Naruhiko Ichiyama, Ayaka Mimura, Hiromichi Yamane, and Yasunari Nagasaki
- Subjects
squamous cell carcinoma ,Immunoglobulin A ,medicine.medical_specialty ,Case Report ,030204 cardiovascular system & hematology ,paraneoplastic syndrome ,Gastroenterology ,IgA vasculitis ,03 medical and health sciences ,0302 clinical medicine ,nephritis ,Internal medicine ,Biopsy ,medicine ,Pharmacology (medical) ,030212 general & internal medicine ,General Pharmacology, Toxicology and Pharmaceutics ,Lung cancer ,Chemical Health and Safety ,Proteinuria ,biology ,medicine.diagnostic_test ,business.industry ,General Medicine ,medicine.disease ,lung cancer ,Purpura ,biology.protein ,medicine.symptom ,business ,Vasculitis ,Safety Research ,Chemoradiotherapy - Abstract
A 72-year-old man with locally advanced lung squamous cell carcinoma experienced red purpura on the lower legs and hematuria when the disease progressed during definitive chemoradiotherapy. He had renal dysfunction and proteinuria. Biopsy specimens of the skin lesion and kidney revealed immunoglobulin A vasculitis. Potential causes such as paraneoplastic syndrome and cancer treatment have been proposed. The administration of steroids rapidly improved the symptoms. The presentation of immunoglobulin A vasculitis is accompanied by malignancies. Clinicians should keep this syndrome in mind, even during curative-intent treatment.
- Published
- 2021